Jullian G. Jones has been appointed as MOMA’s chief business officer. In this role, Dr. Jones will be responsible for guiding MOMA's corporate and business strategy. This will be a busy year as we anticipate filing Investigational New Drug applications with the FDA for our two lead programs.